Medwave gains extension to Novation contract:
This article was originally published in Clinica
Medwave is to continue supplying Novation with its sensor-based, noninvasive blood pressure measuring systems for an additional two years. Danvers, Massachusetts-based Medwave has been supplying Novation, the purchasing organisation for VHA and the University HealthSystem Consortium, since September 2003. Its technology, installed in over 500 hospitals and clinics worldwide, can replace the use of invasive blood pressure monitoring catheters in some patients, says the company.
You may also be interested in...
The Environmental Working Group and Scientific Analytical Institute say inadequate testing of talc-containing personal-care products is to blame for findings of asbestos in cosmetics, including three of 21 powder-based cosmetics SAI analyzed at EWG’s request. They continue to push for updated testing standards that include electron microscopy as a core component.
Commissioner Hahn’s tweet announcing a return to inspections, while not a new policy, may be signal that FDA understands sponsor concerns with the agency’s limited ability to conduct onsite inspections. Effort may be aimed at reassuring industry even as CRLs related to manufacturing increase.
Rushed final rule seeking to impose draconian cuts on drug reimbursement rates in the Medicare Part B program is certain to face legal and political obstacles. But the data included on international price benchmarks will still have an impact.